AXSM News and Press, Axsome Therapeutics Inc. From 04/12/23

2023-04-12 08:35:00 ET Axsome Therapeutics ' (NASDAQ: AXSM) psychiatric drug Auvelity could reach blockbuster status by the end of the decade -- if the company can pull through its current cash crunch. It had just over $200 million in cash and cash equivalents on hand as of Dec. 31,...

2023-04-08 05:52:00 ET For a new bull market to begin, the Nasdaq Composite index must rise at least 20% above its low set on Dec. 28, 2022. The index is currently less than 3% away from reaching that mark. No hype or exaggeration is required to realize that a new Nasdaq bull market...

2023-04-05 09:45:00 ET Biotech stocks can be risky buys as they're often unprofitable and it may be years before they start generating positive cash flow. But one stock that may be a bit safer these days is Axsome Therapeutics (NASDAQ: AXSM) . Although it remains unprofitable, s...

2023-04-04 15:53:30 ET U.S. stock markets are under heavy pressure today after two reports on job openings and factory orders came in weaker than expected. The key issue at play is a growing concern that the Federal Reserve's rate hiking campaign may spark a deep and long-lasting economic d...

2023-04-04 05:30:00 ET Biotech stocks make a great addition to your portfolio at any time. They offer you innovation and, often, huge growth prospects over the long haul. But a biotech company can be particularly interesting as that company gets closer to the finish line with a potentia...

2023-04-01 06:14:00 ET Some stocks are sort of like the late comedian Rodney Dangerfield; they "don't get no respect." Others get some respect, but not the respect they probably deserve. Their market valuations just don't reflect their full potential. We asked three Motley Fool cont...

2023-03-25 06:00:00 ET Nearly every giant company started out as a much smaller one. Investors who got in early were able to realize huge returns. So which smaller companies have the potential to grow much larger today? Three Fool.com contributors have ideas on up-and-coming growth stoc...

2023-03-17 16:16:22 ET Summary Here's a long list of biopharmas exposed to SVB Financial Group. Many of these deposits will be uninsured. However, since SVB Financial Group was quite solvent otherwise, much of these deposits should be recoverable by these small companies. ...

2023-03-10 16:20:13 ET Axsome ( NASDAQ: AXSM ) Therapeutics closed down Friday ~6% , and is down another 2% in post-market trading after saying it has "material" deposits with both FDIC-shuttered SVB Financial ( SIVB ) and Citi ( C ). In an SEC filing, the ...

2023-03-09 14:52:53 ET Summary Given that Axsome Therapeutics, Inc. is launching Auvelity with a small in-house team, you can expect a substantial sales increase in the next three years. In a highly favorable deal, Axsome recently out-licensed its ex-USA rights of Sunosi to Pharma...